-
International Lung Cancer Conference | Dr. Panwen Tian: Exploration and Practice of Biomarkers in Lung Cancer Immunotherapy
The exploration of biomarkers in immunotherapy is constantly evolving, yet only a few have proven to effectively guide clinical decision-making. At the 2024 International Lung Cancer Conference (CLC 2024), held from August 9-11, Dr. Panwen Tian from West China Hospital of Sichuan University delivered a keynote speech titled “Thoughts and Exploration of Biomarkers in Lung…
-
2024 COMB丨Dr. Tao Sun: Advancements in HER2+ EBC Treatment—De-escalation Therapy and the Future of ctDNA Applications
In recent years, the field of breast cancer treatment has witnessed a series of innovative research developments, particularly in the treatment of HER2+ early breast cancer (EBC). Strategies such as “de-escalation,” “chemotherapy-free,” and “precision treatment” have become hot topics. At the 7th Oncology Precision Diagnosis and Treatment Conference and the 10th Breast Cancer Individualized Treatment…
-
2024 COMB丨Dr. Jiani Wang: Insights on the ADAPT Study and New Advances in Precision Treatment for HER2+ Breast Cancer
At the full-session management segment of the 7th Oncology Precision Diagnosis and Treatment Conference and the 10th Breast Cancer Individualized Treatment Conference (2024 COMB), Dr. Jiani Wang from the Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, along with three other breast cancer experts, engaged in a deep discussion on…
-
Dr Vincent Wong: Lean metabolic associated fatty liver disease from a clinical perspective
The Combined GlHep&SHC 2024 will be held in Singapore from July 25th to 28th, 2024. This conference brings together elite scholars in the field of liver disease from around the world to discuss the latest developments, challenges, and opportunities in liver disease. Hepatology Digest invited Dr Vincent Wong from The Chinese University of Hong Kong…
-
Dr Lim Seng Gee: Looking forward to the emergence of new treatment methods for MAFLD in the future
Recently, the Combined GlHep&SHC 2024 was held in Singapore. This conference covers various aspects of liver disease research and provides an interdisciplinary communication platform for experts and scholars. During the conference, Hepatology Digest conducted an exclusive interview with Professor Lim Seng Gee from the National University Hospital of Singapore, asking him to introduce the current…
-
Continuing the Miracle of Healing, Interview with Dr. Christian Gaebler, Speaker of “The Next Berlin Patient” | AIDS 2024
At the just concluded 25th International Conference on AIDS (AIDS2024), as a major clinical research progress of the conference, Dr. Christian Gaebler of Charlotte University in Berlin, Germany, reported the seventh “next Berlin patient” to be cured after the world’s first “Berlin patient” cured of HIV. This patient did not follow the traditional path of…
-
AIDS Interview | New Breakthrough of Broad Spectrum Neutralizing Antibodies (bnAbs) in HIV Prevention and Treatment
Broad spectrum neutralizing antibodies (bnAbs) are showing unprecedented potential in the field of HIV prevention and treatment. At the 25th International AIDS Conference (AIDS2024), Professor Hyman Scott, medical director of Bridge HIV clinical research, San Francisco Department of Public Health, introduced the latest progress of bnAbs in HIV prevention and treatment. Infectious Disease Frontier（IIDF） is…
-
2024 CUDA丨Dr. Kan Gong: Addressing Clinical Needs in mHSPC and Bringing More Benefits to Patients Through Novel Endocrine Therapies
In the stage of metastatic hormone-sensitive prostate cancer (mHSPC), effective treatment is crucial to delaying the progression to castration-resistant stages (mCRPC), thereby extending patient survival. From August 8-11, 2024, the Annual Meeting of the Urological Surgeon Branch of the Chinese Medical Doctor Association (CUDA) was grandly held in Xi’an, Shaanxi Province. At the conference, Dr.…
Connecting Medical Expertise through Media